Business
ASX 200 investors underexposed to this potential ‘great news event’ – Motley Fool Australia
If an effective vaccine against the coronavirus were uncovered this week, many ASX 200 investors would be poorly positioned to benefit.
The silver bullet to slay the coronavirus and return life to normal remains elusive. But that doesn’t mean it might not be here sooner than most S&P/ASX 200 Index (ASX: XJO) investors are pricing in.
The world’s top institutions and brightest minds are working around the clock, after all, with record amounts of private and government funding pouring in.
However, recent setbacks with some leading vaccine trials, alongside announcements that any new vaccines may only prove 50–60% effective, …
-
Noosa News12 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General10 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General18 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
Noosa News20 hours agoInquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family